Pilot AMC for pneumococcal disease
To accelerate the development and availability of new vaccines against pneumococcal disease, Italy, the UK, Canada, Norway, Russia, and the Bill & Melinda Gates Foundation together committed US$ 1.5 billion to finance a pilot Advance Market Commitment (AMC).